Related Experiment Video
Updated: May 23, 2026

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
Early graft failure after heart transplant: risk factors and implications for improved donor-recipient matching
Cristiano Amarelli1, Luca Salvatore De Santo, Claudio Marra
1Department of Cardiovascular Surgery and Transplants, Monaldi Hospital, Naples, Italy.
Insights
Early graft failure (EGF) after heart transplantation (HT) is a serious complication with poor outcomes. Identifying risk factors like donor-recipient mismatch is crucial for prevention.
Area of Science:
- Cardiology
- Transplantation Immunology
Background:
- Early graft failure (EGF) remains a significant challenge after heart transplantation (HT).
- Current therapeutic options for EGF are limited, and the prognosis is generally poor.
- Understanding risk factors is essential for improving patient outcomes.
Purpose of the Study:
- To identify risk factors associated with early graft failure (EGF) after heart transplantation (HT).
- To evaluate the clinical impact and outcomes of EGF.
- To stratify patients based on EGF risk and compare outcomes.
Main Methods:
- Retrospective analysis of 317 consecutive heart transplants (HT) performed between January 1999 and December 2008.
- Bivariate and multivariable discriminant analyses to identify significant risk factors for EGF.
- Propensity score derivation to stratify patients into low, intermediate, and high-risk groups for EGF.
Main Results:
- Early graft failure (EGF) occurred in 10.1% of patients, with rates of 2.9%, 3.8%, and 23.6% in the low, intermediate, and high-risk groups, respectively.
- EGF-related mortality was 56.3% overall, with higher rates in the high-risk group (48-100%).
- Key predictors of EGF in the highest-risk group included redo procedures, valvular cardiomyopathy, recipient status, donor-recipient weight mismatch, donor support, ischemic time, and troponin I levels.
Conclusions:
- Several donor and recipient characteristics significantly predict early graft failure (EGF) after heart transplantation (HT).
- These risk factors, while not easily modifiable, synergistically contribute to EGF occurrence.
- Optimizing donor-recipient matching is a critical strategy for preventing EGF and improving long-term transplant success.
Abstract:
Early graft failure (EGF) is a dreaded complication after heart transplantation (HT). Despite several improvements, no effective therapy has been developed and the prognosis is poor. We evaluated the risk factors and clinical impact of EGF. In a consecutive series of 317 HTs performed at a single institution between January 1999 and December 2008, variables associated significantly with EGF were sought in bivariate and multivariable discriminant analyses. The deriving propensity score was used to stratify the study sample in to three groups (low, intermediate and high risk for EGF). Comparisons were performed between the higher-risk group and the remaining population in terms of preoperative features and outcomes. EGF occurred in 10.1% of the overall population (2.9, 3.8 and 23.6%, respectively, in the three groups). Overall, EGF-related mortality was 56.3% (100, 75 and 48%, respectively, in the three groups). Determinants of EGF in the highest-risk group were: redo procedure, valvular cardiomyopathy, status one at transplant, recipient male sex, donor-recipient (D/R) weight mismatch, high inotropic donor support, ischaemic time and first day troponin I release. In conclusion, several donor and recipient features predicted EGF. Since such characteristics are not readily modifiable but synergistically determine the occurrence of EGF, optimization of D/R matching is crucial to prevent it.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

